[Fetal hydantoin syndrome].
We present the clinical picture of a patient with the fetal hydantoin syndrome. A review was made on etiology, pathogenesis, in this syndrome and the recommended medical management for the epileptic mother during pregnancy.
D000014:Abnormalities, Drug-Induced / Q000209:etiology*; D000015:Abnormalities, Multiple / Q000139:chemically induced*; D004359:Drug Therapy, Combination; D004374:Ductus Arteriosus, Patent / Q000139:chemically induced; D004827:Epilepsy / Q000188:drug therapy; D005260:Female; D005333:Fetus / Q000187:drug effects*; D006554:Hernia, Umbilical / Q000139:chemically induced; D006801:Humans; D007231:Infant, Newborn; D007236:Infant, Small for Gestational Age; D008431:Maternal-Fetal Exchange; D008831:Microcephaly / Q000139:chemically induced; D010634:Phenobarbital / Q000008:administration & dosage; D010672:Phenytoin / Q000008:administration & dosage / Q000009:adverse effects*; D011247:Pregnancy
D010672:Phenytoin; D010634:Phenobarbital
Síndrome fetal hidantoínico.